NASDAQ NMS - GLOBAL MARKET · FDMT
-4.16% · -$0.6700 · Vol 921.2K
Market closed · last close 4:00 PM ET · price as of 18:07:21 ET
4D Molecular Therapeutics Inc

4D Molecular Therapeutics Inc

Biotechnology
$15.43
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Earnings absence reason unknown
FDMT
4D Molecular Therapeutics Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is FDMT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading FDMT catalysts
About 4D Molecular Therapeutics Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2020
Employees
196
Country
US

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$16.32
Day high
$16.91
Day low
$15.33
Previous close
$16.10
52W high
$16.91
-8.75% from high
52W low
$6.14
86% of range
Market cap
$874.5M
EPS
$-4.0400
Beta
1.76
Shares out
55.2M
Volume
921.2K
1.07× rel vol
Avg volume
860.1K
VWAP
$15.94
Price history computed in-house
1W
+6.08%
1M
+53.23%
3M
+77.15%
1Y
+117.63%
YTD
+105.73%
SMA 50 $11.51 · above
SMA 200 $9.89 · above
52W position 86%

FDMT overview

Veridion Score
59
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around FDMT.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading FDMT Form 4 filings
Public disclosures

Congress activity in FDMT

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for FDMT in the cached public ledger.

Federal contracts

FDMT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FDMT in this window.
Lobbying spend

FDMT lobbying filings, year to date.

Registered lobbying filings matched to 4D Molecular Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FDMT in this window.
Loading news for FDMT
Analyst ratings
Sovereign unlock shows live analyst consensus for FDMT.
Options
Sovereign unlock shows live options positioning for FDMT.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.